Controlled substances are basically controlled drugs or prescribed medications, which are designated by the law and their production & use are regulated by the government. These controlled substances or controlled prescribed medications are used in treatment of several types of neurological disorders as well as in drug research. Various product types of controlled substances are, opioids, stimulants, depressants, and cannabinoids drugs.
The U.S. controlled substance market is likely to grow at a steady pace during the forecast period, owing to the increasing demand for controlled substances as drugs on chronic pain.
Request a Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84832
High Incidence Rate of Chronic Pain among Geriatric Population to Drive Demand for Controlled Substances in U.S.
Chronic pain persists for a longer duration, and the number of patients suffering from chronic pain is increasing. According to data provided by the Centers for Disease Control and Prevention, in 2019, an estimated 20.4% adults in the U.S. had chronic pain, and 7.4% adults had high-impact chronic pain.
Moreover, increase in geriatric population that is more prone to chronic pain, due to reduced mobility and lack of activity, is projected to propel to demand for controlled substance. The WHO stated that the growth rate of the geriatric population would be higher in developed countries, especially in countries such as the U.S. According to the U.S. Census Bureau, around 89 million people are expected to be aged over 65 years in the U.S. by 2050.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84832
Introduction of New Controlled Substance Products to Boost Market in U.S.
The launch of new products is estimated to boost the market, as this would provide more options for effective treatment. Controlled drugs for depression, or other drugs such as amphetamine, which are available in the market in different forms can be easily abused, primarily by adolescents. Several pharmaceutical companies are taking interest or initiatives to introduce some new products or capsule control drugs in the market in order to provide better treatment to people suffering from chronic diseases. For instance, in 2020, Trevena, Inc., a biopharmaceutical company, received the U.S. FDA approval for its brand OLINVYK (oliceridine) injection for the management of acute pain in adults. In addition, the FDA recently approved cocaine-based products, such as C-Topical in topical form, to provide anesthetic support during procedures.
Opioid Segment to Lead U.S. Controlled Substance Market
Opioid is basically used to treat moderate to severe pain. The growth of the opioid segment can be attributed to the consistent rise in population that suffers from pain, and an opioid is used as a component in the management of pain. Awareness about the advantages of these drugs to treat different types of pain and availability through different distribution channels, such as online mode prescribed by specialists, have increased considerably. Therefore, a rise in the demand for opioids for use in pain management is one of the major reasons that boosts the market.
In terms of revenue, the opioid product type segment accounted for a dominant share of the market in 2021. The segment is anticipated to expand at a high CAGR rate from 2022 to 2031.
Ask for a custom report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84832
Need for Pain Management to Drive Demand for Controlled Drugs
The pain management segment is projected to account for a notable share of the global market. Pain can lead to severe complications if proper care or treatment is not provided for a longer time. Unattained pain results in many health issues such as vein thrombosis, reduced patient mobility, and pulmonary embolism. Therefore, doctors usually prescribe analgesics in the initial stage of pain. If the patient remains unresponsive for the initial medications then, these controlled drugs are used for further treatment. Thus, this increase in use of controlled drugs is estimated to fuel the demand for controlled substances.
Geriatric individuals and people suffering from chronic pain caused by cancer and other diseases can be effectively treated with controlled substance drugs; hence, an increase in usage of controlled substances is estimated to propel the market significantly during the forecast period.
About Transparency Market Research
Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research firm that offers market analysis reports and business consulting. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit our YouTube channel –
https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact Us:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: 1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]